Your browser doesn't support javascript.
loading
The A118G single-nucleotide polymorphism in OPRM1 is a risk factor for asthma severity.
Kawakami, Kaori; Miyasaka, Tomomitsu; Nakamura, Yutaka; Metoki, Hirohito; Miyata, Satoshi; Sato, Miki; Sora, Ichiro; Yamauchi, Kohei; Kawakami, Kazuyoshi; Blendy, Julie A; Kawano, Tasuku; Shimokawa, Hiroaki; Takayanagi, Motoaki; Ohno, Isao; Takahashi, Tomoko.
Afiliación
  • Kawakami K; Division of Pathophysiology, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Miyasaka T; Division of Pathophysiology, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan. Electronic address: t-miya13@tohoku-mpu.ac.jp.
  • Nakamura Y; Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Iwate, Japan.
  • Metoki H; Division of Public Health, Hygiene and Epidemiology, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Miyata S; Teikyo University Graduate School of Public Health, Tokyo, Japan.
  • Sato M; Division of Pathophysiology, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Sora I; Department of Psychiatry, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Yamauchi K; Division of Pulmonary Medicine, Allergy, and Rheumatology, Department of Internal Medicine, Iwate Medical University School of Medicine, Iwate, Japan.
  • Kawakami K; Department of Medical Microbiology, Mycology and Immunology, Tohoku University Graduate School of Medicine, Sendai, Japan; Department of Intelligent Network for Infection Control, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Blendy JA; Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Medical School, Philadelphia, PA, USA.
  • Kawano T; Division of Pathophysiology, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Shimokawa H; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
  • Takayanagi M; Division of Pathophysiology, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Ohno I; Center for Medical Education, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
  • Takahashi T; Division of Pathophysiology, Department of Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Allergol Int ; 71(1): 55-65, 2022 Jan.
Article en En | MEDLINE | ID: mdl-34688555
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Asma / Índice de Severidad de la Enfermedad / Receptores Opioides mu Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Allergol Int Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Asma / Índice de Severidad de la Enfermedad / Receptores Opioides mu Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Allergol Int Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2022 Tipo del documento: Article